Stream 3 Session #11: Drug Discovery in Metabolism
Tracks
Meeting Room 105 & 106
| Friday, August 21, 2026 |
| 4:00 PM - 6:00 PM |
| Meeting Room 105 & 106 (Level 1) |
Speaker
Dr Sahar Keshvari
Senior Research Officer
Mater Research / University of Queensland
Macrophage Colony Stimulating Factor (CSF1) promotes resolution of fibrosis and steatosis in preclinical models of metabolic dysfunction-associated steatotic liver disease.
5:40 PM - 5:55 PMBiography
Dr Sahar Keshvari is an emerging leader and NHMRC Investigator Grant recipient driving innovative research on immune‑metabolic pathways. Her work is uncovering new mechanisms and potential treatments for diabetes‑related metabolic dysfunction and liver disease, aiming to transform outcomes for people living with these conditions.